The biotech company Mannin is also present at “Bio Europe”. The company is based in Bio City Leipzig and researches treatment methods for the glaucoma, Managing Director Isabel Antholz explained: "Our approach is a vascular repair or treatment that can occur in different parts of the body."
The idea behind it: a bio-marker should recognize earlier if a patient has a glaucoma. Therapy could then begin immediately. The company also wants to develop eye drops that better stop the progression of the disease, says Antholz: "We want to offer better therapies than those that are already available today."
Cooperation needed for medicines
The company wants to establish contacts for cooperation at the trade fair, said Managing Director Antholz: “It is a huge opportunity for us that the trade fair is in Saxony this year. This allows us to become much better known.” No company can act on its own in the industry, but needs collaborations, says Antholz: "We need knowledge from very different areas in order to be able to develop a drug and bring it to market."
25.000 people employed in biotechnology
Biotechnology is one of the central future industries, said the State Secretary in the Saxon Ministry of Economic Affairs, Thomas Kralinski, at the fair: "Biotechnology can make a contribution to being able to cure diseases that we cannot cure at the moment." More than 200 million euros have flowed into the industry for research purposes in recent years, said Kralinski. In addition, 25.000 people are employed in biotechnology in Saxony. “Leipzig and Dresden are a hotspot within Germany, but also in Europe. The attraction of the cities is great,” says Kralinski.
Source: mdr Saxony from 24.10.2022